MACROGENICS INC — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2023-05-31

Reporting Person: HEIDEN WILLIAM K (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-31	Stock Option (right to buy)	$4.67	A	19000	Acquired	2033-05-31	Common Stock (19000)	Direct
2023-05-31	Restricted Stock Unit	$0	A	4500	Acquired		Common Stock (4500)	Direct

Footnotes

F1: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.

F3: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier